ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD— 510(k) K022331
Substantially EquivalentBayer Diagnostics Corp.
FDA 510(k) clearance K022331 for ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD, Substantially Equivalent on 2002-09-11. Applicant: Bayer Diagnostics Corp..
Clearance details
- Applicant
- Bayer Diagnostics Corp.
- Product code
- Code GKL
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Tarrytown, NY, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.